Αποτελέσματα Αναζήτησης
25 Νοε 2019 · CapVest, which specializes in mid-market buyouts, has hired JPMorgan and Rothschild to find a new owner for the Paris-based firm which makes nuclear tracers used in diagnostic imaging ...
8 Απρ 2024 · (Paris, France – 8 th April 2024) – Curium, a world leader in nuclear medicine, announced today that it has entered into an agreement with Eczacıbaşı Holding and Bozlu Group for the acquisition of Eczacıbaşı-Monrol Nuclear Product Co. (Monrol), a dedicated specialist in nuclear medicine.
8 Απρ 2024 · PARIS, April 08, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has entered into an agreement with Eczacıbaşı Holding and Bozlu Group for the...
Limited partners in the 2013-vintage CapVest Equity Partners III were given the opportunity to sell their holdings in nuclear medicine company Curium Pharma or roll into a continuation vehicle, according to two sources familiar with the matter.
9 Ιαν 2020 · CVC Capital Partners, Bain Capital, Clayton Dubilier & Rice, Nordic Capital and PAI Partners have submitted first-round bids to acquire Curium Pharma from CapVest in a deal that would value the company at $3 billion or more, according to Bloomberg.
26 Απρ 2023 · Curium Pharma, a French maker of medical imaging supplies, and buyout firm HIG Capital are among suitors shortlisted in the bidding for Cardinal Health Inc. ’s nuclear medicine business,...
20 Οκτ 2020 · Intermediate Capital Group (ICG) is indirectly acquiring over 25% of the shares of Europe's largest radiopharmaceuticals provider Curium Pharma, HBI can reveal, after owner Capvest earlier pulled a majority sales process because of COVID-19.
